Literature DB >> 19778204

Existence of the lymphatic system in the primate corpus luteum.

Fuhua Xu1, Richard L Stouffer.   

Abstract

To date, there have been no detailed studies on the lymphatic system in the primate corpus luteum (CL); early reports suggested that the presence of this "secondary circulation" in luteal tissue is species-dependant. Therefore, studies were designed to determine if (a) lymphatic vessels exist, and (b) recently discovered lymphangiogenic factors and their receptor are expressed in the macaque CL during the menstrual cycle. Immunohistochemistry (IHC) detected the lymphatic endothelial cell marker, lymphatic vessel endothelial hyaluronan receptor 1 (LYVE1), in some endothelial cells and vessels within the ovarian stroma and theca layer of preovulatory follicles and in the CL. Dual fluorescent IHC demonstrated that LYVE1 co-localized with another lymphatic endothelial cell marker D2-40, but a blood vascular endothelial cell marker (von Willebrand Factor, VWF) was in different cells. The numbers and staining intensity of LYVE1-positive cells in the CL appeared to increase from early to mid luteal phase, and remained elevated thereafter. RT-PCR detected cDNA fragments for mRNAs encoding VEGFC, FIGF, and their receptor FLT4 in CL. Real-time PCR analyses revealed similar patterns of VEGFC and FLT4 expression during the luteal lifespan; mRNA levels increased (p < 0.05) from early to mid luteal phase and decreased (p < 0.05) by late luteal phase. In contrast, FIGF levels were elevated initially, declined (p < 0.05) at mid luteal phase, and then increased (p < 0.05) to very late luteal phase. The data strongly suggest that lymphatic vessels are present in the primate CL, and that the VEGFC/FIGF-FLT4 system regulates lymphangiogenesis and luteal structure-function during the menstrual cycle.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19778204      PMCID: PMC2991194          DOI: 10.1089/lrb.2009.0009

Source DB:  PubMed          Journal:  Lymphat Res Biol        ISSN: 1539-6851            Impact factor:   2.589


  55 in total

1.  Mouse LYVE-1 is an endocytic receptor for hyaluronan in lymphatic endothelium.

Authors:  R Prevo; S Banerji; D J Ferguson; S Clasper; D G Jackson
Journal:  J Biol Chem       Date:  2001-02-20       Impact factor: 5.157

Review 2.  Lymphangiogenesis and lymphangiodysplasia: from molecular to clinical lymphology.

Authors:  M H Witte; M J Bernas; C P Martin; C L Witte
Journal:  Microsc Res Tech       Date:  2001-10-15       Impact factor: 2.769

3.  A model for gene therapy of human hereditary lymphedema.

Authors:  M J Karkkainen; A Saaristo; L Jussila; K A Karila; E C Lawrence; K Pajusola; H Bueler; A Eichmann; R Kauppinen; M I Kettunen; S Yla-Herttuala; D N Finegold; R E Ferrell; K Alitalo
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-09       Impact factor: 11.205

4.  Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice.

Authors:  T Veikkola; L Jussila; T Makinen; T Karpanen; M Jeltsch; T V Petrova; H Kubo; G Thurston; D M McDonald; M G Achen; S A Stacker; K Alitalo
Journal:  EMBO J       Date:  2001-03-15       Impact factor: 11.598

5.  Monoclonal antibody D2-40, a new marker of lymphatic endothelium, reacts with Kaposi's sarcoma and a subset of angiosarcomas.

Authors:  Harriette J Kahn; Denis Bailey; Alexander Marks
Journal:  Mod Pathol       Date:  2002-04       Impact factor: 7.842

Review 6.  Current biology of VEGF-B and VEGF-C.

Authors:  B Olofsson; M Jeltsch; U Eriksson; K Alitalo
Journal:  Curr Opin Biotechnol       Date:  1999-12       Impact factor: 9.740

7.  Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3.

Authors:  T Mäkinen; L Jussila; T Veikkola; T Karpanen; M I Kettunen; K J Pulkkanen; R Kauppinen; D G Jackson; H Kubo; S Nishikawa; S Ylä-Herttuala; K Alitalo
Journal:  Nat Med       Date:  2001-02       Impact factor: 53.440

8.  Differential expression of lactate dehydrogenase isozymes (LDH) in human placenta with high expression of LDH-A(4) isozyme in the endothelial cells of pre-eclampsia villi.

Authors:  S C Tsoi; J Zheng; F Xu; H H Kay
Journal:  Placenta       Date:  2001-04       Impact factor: 3.481

9.  Dynamic expression of mRNAs and proteins for matrix metalloproteinases and their tissue inhibitors in the primate corpus luteum during the menstrual cycle.

Authors:  K A Young; J D Hennebold; R L Stouffer
Journal:  Mol Hum Reprod       Date:  2002-09       Impact factor: 4.025

10.  The transcription factor Prox1 is a marker for lymphatic endothelial cells in normal and diseased human tissues.

Authors:  Jörg Wilting; Maria Papoutsi; Bodo Christ; Kypros H Nicolaides; Constantin S von Kaisenberg; Jörg Borges; G Björn Stark; Kari Alitalo; Stanislav I Tomarev; Charlotte Niemeyer; Jochen Rössler
Journal:  FASEB J       Date:  2002-06-07       Impact factor: 5.191

View more
  7 in total

Review 1.  Lymphatic Vessel Network Structure and Physiology.

Authors:  Jerome W Breslin; Ying Yang; Joshua P Scallan; Richard S Sweat; Shaquria P Adderley; Walter L Murfee
Journal:  Compr Physiol       Date:  2018-12-13       Impact factor: 9.090

Review 2.  Endocrine and local control of the primate corpus luteum.

Authors:  Richard L Stouffer; Cecily V Bishop; Randy L Bogan; Fuhua Xu; Jon D Hennebold
Journal:  Reprod Biol       Date:  2013-09-14       Impact factor: 2.376

3.  VEGFR-3 neutralization inhibits ovarian lymphangiogenesis, follicle maturation, and murine pregnancy.

Authors:  Joseph M Rutkowski; Jong Eun Ihm; Seung Tae Lee; Witold W Kilarski; Veronique I Greenwood; Miriella C Pasquier; Alexandra Quazzola; Didier Trono; Jeffrey A Hubbell; Melody A Swartz
Journal:  Am J Pathol       Date:  2013-09-13       Impact factor: 4.307

Review 4.  Immune and vascular contributions to organogenesis of the testis and ovary.

Authors:  Xiaowei Gu; Shu-Yun Li; Tony DeFalco
Journal:  FEBS J       Date:  2021-04-12       Impact factor: 5.622

Review 5.  Hypertension and reproductive dysfunction: a possible role of inflammation and inflammation-associated lymphangiogenesis in gonads.

Authors:  Shobana Navaneethabalakrishnan; Bethany L Goodlett; Alexandra H Lopez; Joseph M Rutkowski; Brett M Mitchell
Journal:  Clin Sci (Lond)       Date:  2020-12-23       Impact factor: 6.876

6.  Three-dimensional imaging of Prox1-EGFP transgenic mouse gonads reveals divergent modes of lymphangiogenesis in the testis and ovary.

Authors:  Terje Svingen; Mathias François; Dagmar Wilhelm; Peter Koopman
Journal:  PLoS One       Date:  2012-12-20       Impact factor: 3.240

7.  Lymphatic involvement in the disappearance of steroidogenic cells from the corpus luteum during luteolysis.

Authors:  Hironori Abe; Mohamad Omar Al-zi'abi; Fumio Sekizawa; Tomas J Acosta; Dariusz J Skarzynski; Kiyoshi Okuda
Journal:  PLoS One       Date:  2014-02-20       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.